Cencora, Inc. (COR)
NYSE: COR · Real-Time Price · USD
275.21
+1.24 (0.45%)
At close: Mar 28, 2025, 4:00 PM
274.87
-0.34 (-0.12%)
After-hours: Mar 28, 2025, 8:00 PM EDT
Cencora Employees
Cencora had 46,000 employees as of September 30, 2023. The number of employees increased by 2,000 or 4.55% compared to the previous year.
Employees
46,000
Change (1Y)
2,000
Growth (1Y)
4.55%
Revenue / Employee
$6,591,148
Profits / Employee
$30,353
Market Cap
53.37B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Sep 30, 2023 | 46,000 | 2,000 | 4.55% |
Sep 30, 2022 | 44,000 | 2,000 | 4.76% |
Sep 30, 2021 | 42,000 | 20,000 | 90.91% |
Sep 30, 2020 | 22,000 | 0 | - |
Sep 30, 2019 | 22,000 | 1,000 | 4.76% |
Sep 30, 2018 | 21,000 | 1,000 | 5.00% |
Sep 30, 2017 | 20,000 | 1,000 | 5.26% |
Sep 30, 2016 | 19,000 | 1,500 | 8.57% |
Sep 30, 2015 | 17,500 | 3,500 | 25.00% |
Sep 30, 2014 | 14,000 | 1,000 | 7.69% |
Sep 30, 2013 | 13,000 | -1,500 | -10.34% |
Sep 30, 2012 | 14,500 | 4,200 | 40.78% |
Sep 30, 2011 | 10,300 | 300 | 3.00% |
Sep 30, 2010 | 10,000 | -300 | -2.91% |
Sep 30, 2009 | 10,300 | -600 | -5.50% |
Sep 30, 2008 | 10,900 | -400 | -3.54% |
Sep 30, 2007 | 11,300 | -3,400 | -23.13% |
Sep 30, 2006 | 14,700 | 1,300 | 9.70% |
Sep 30, 2005 | 13,400 | -700 | -4.96% |
Sep 30, 2004 | 14,100 | -700 | -4.73% |
Sep 30, 2003 | 14,800 | 1,100 | 8.03% |
Sep 30, 2002 | 13,700 | 0 | - |
Sep 30, 2001 | 13,700 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
COR News
- 1 day ago - Cencora Announces Date and Time for Second Quarter Fiscal 2025 Earnings Release - Business Wire
- 4 weeks ago - Cencora: Higher Potential Returns After Reduced Walgreens Stake - Seeking Alpha
- 7 weeks ago - Cencora Announces Common Share Repurchase From Walgreens Boots Alliance - Business Wire
- 7 weeks ago - Walgreens Boots Alliance Early-Settles Certain Prepaid Variable Share Forward Transactions and Sells Related Shares of Cencora For Approximately $300 Million of Proceeds - Business Wire
- 7 weeks ago - Cencora Reinforces Efforts to Strengthen Pharmaceutical Supply Chain with Expansion of Drug Shortages Mitigation Program - Business Wire
- 7 weeks ago - Cencora (COR) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Cencora raises 2025 profit forecast on specialty drug demand - Reuters
- 7 weeks ago - Cencora Reports Fiscal 2025 First Quarter Results - Business Wire